Observational studyAdvances in therapy2025

Long-Term Safety and Efficacy of Pemafibrate to Treat Hyperlipidemia: Post-marketing Surveillance Over a 24-Month Observation Period in Japan.

Mao Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.